Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.
Factors Associated with Willingness to Enter Drug Treatment: Some Implications for Policy
AIDS & Public Policy Journal 5, no. 3 (Summer 1990): 112-16 Jeanne Kleyn and Elise S. Lake
As part of a pilot study, intravenous drug users in Seattle, Washington, were asked about their willingness to enter drug treatment, behaviors that might put them at risk for HIV transmission, and their socioeconomic and demographic characteristics. Their responses to those questions and the relationships between those variables are examined below. Finally, the implications of these results for drug treatment policy are examined. A street sample of 78 out-of-treatment intravenous drug users in a low income, multiethnic neighborhood in central Seattle was selected using a modified chain referral technique. Regulations governing research with human subjects did not allow the recruitment of subjects under 18. Otherwise, recruitment efforts were designed to assure at least some representation of the racial, ethnic, sexual, and age groups the ethnographer identified as important. Subjects were recruited directly, through referrals from other intravenous drug users and with flyers posted at known gathering places (e.g., street corners, bars, restaurants) of possible respondents. More than half (55.1 percent) of those who were interviewed said that they would be willing to enter drug treatment if a placement wee available immediately. Bivariate and logistic regression analysis indicated that willingness to enter treatment was associated both with respondents' drug-related risk for HIV transmission and with certain demographic and socioeconomic characteristics.
900315
APPJ905303
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.
